Sangamo Therapeutics
SGMO
#8725
Rank
HK$1.29 B
Marketcap
HK$3.86
Share price
-6.45%
Change (1 day)
-74.83%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -HK$0.85 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are HK$32.87 Million. In 2024 the company made an earning of -HK$0.77 Billion, an increase over its 2023 earnings that were of -HK$0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.85 Billion10.83%
2024 -HK$0.77 Billion-17.27%
2023 -HK$0.93 Billion-40.88%
2022 -HK$1.57 Billion9.79%
2021 -HK$1.43 Billion41.52%
2020 -HK$1.01 Billion23.17%
2019 -HK$0.82 Billion36.33%
2018 -HK$0.61 Billion36.89%
2017 -HK$0.44 Billion-22.32%
2016 -HK$0.57 Billion54.86%
2015 -HK$0.37 Billion75.62%
2014 -HK$0.21 Billion0.13%
2013 -HK$0.21 Billion
2011 -HK$0.28 Billion43.66%
2010 -HK$0.2 Billion28.52%
2009 -HK$0.16 Billion-23.55%
2008 -HK$0.2 Billion2.45%
2007 -HK$0.2 Billion19.5%
2006 -HK$0.17 Billion50.78%
2005 -HK$0.11 Billion75%
2004 -HK$61.14 Million-33.25%
2003 -HK$91.59 Million-62.27%
2002 -HK$0.25 Billion102.82%
2001 -HK$0.12 Billion23.21%
2000 -HK$97.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
HK$76.93 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.15 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.81 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-HK$5.79 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.09 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.68 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA